Market Tracker

11/28 4:24am ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

--
Data as of --
-- -- / --
Today’s Change
6.20
Today|||52-Week Range
31.73
--
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close6.46
Today’s open--
Day’s range-- - --
Volume--
Average volume (3 months)--
Market cap$65.3M
Dividend yield--
Data as of --

Growth & Valuation

Earnings growth (last year)+1.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book6.31

Competitors

 Today’s
change
Today’s
% change
IPCIIntelliPharmaCeutics...+0.14+5.00%
COCPCocrystal Pharma Inc-0.01-2.09%
GLMDGalmed Pharmaceutica...-0.16-2.72%
VCELVericel Corp+0.06+2.34%
Data as of 3:54pm ET, 11/26/2014

Financials

Next reporting dateJanuary 28, 2015
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$4.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts